Hoey Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71K Hold
7
﹤0.01% 343
2026
Q1
$2.05K Hold
7
﹤0.01% 341
2025
Q4
$2.45K Hold
7
﹤0.01% 337
2025
Q3
$2.26K Hold
7
﹤0.01% 335
2025
Q2
$2.72K Hold
7
﹤0.01% 325
2025
Q1
$3.04K Hold
7
﹤0.01% 280
2024
Q4
$2.58K Hold
7
﹤0.01% 279
2024
Q3
$3.79K Hold
7
﹤0.01% 269
2024
Q2
$3.79K Hold
7
﹤0.01% 269
2024
Q1
$3.63K Hold
7
﹤0.01% 266
2023
Q4
$3.3K Hold
7
﹤0.01% 271
2023
Q3
$3.05K Hold
7
﹤0.01% 280
2023
Q2
$3.11K Hold
7
﹤0.01% 276
2023
Q1
$3.22K Buy
+7
New +$3.33K ﹤0.01% 281

Other funds holding ELV

Hoey Investments's ELV Position: Q2 2026 in Review

Hoey Investments held its Elevance Health (ELV) position steady in Q2 2026 at 7 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #343.

Hoey Investments first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.79K in Q3 2024. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hoey Investments held 7 shares of Elevance Health worth $2.71K as of Q2 2026.
  • Hoey Investments left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Hoey Investments's portfolio in Q2 2026, its #343 holding.
  • Hoey Investments first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • Hoey Investments's Elevance Health position peaked at $3.79K in Q3 2024.
  • 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hoey Investments's 13F filing for Q2 2026, filed 27 Jul 2026.